Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. [electronic resource]
Producer: 20190701Description: 198 p. digitalISSN:- 1471-2407
- Humans
- Antineoplastic Agents, Alkylating -- therapeutic use
- Brain Neoplasms -- therapy
- Chemoradiotherapy -- methods
- Glioblastoma -- therapy
- Phthalazines -- therapeutic use
- Piperazines -- therapeutic use
- Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
- Radiotherapy, Intensity-Modulated -- methods
- Temozolomide -- therapeutic use
- Multicenter Studies as Topic
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Adolescent
- Young Adult
- Adult
- Middle Aged
- Aged
- Radiation-Sensitizing Agents -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial Protocol; Journal Article
There are no comments on this title.
Log in to your account to post a comment.